Presentation ACC 2024

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Presenter: C. Michael Gibson

April 06, 2024

REGISTER for free or LOG IN to view this content

ApoA-I Event ReducinG in Ischemic Syndromes II (AEGIS-II) Trial

Coronary

CAD Pharma

ACC 2024

Up Next

Presentation ACC 2024

Principal Results from the RELIEVE-HF Trial

Presenter: Gregg W. Stone

April 06, 2024

More slides +

Presentation ACC 2024

Acoramidis May Improve Cardiac Function and Promote Regression in Transthyretin Amyloid Cardiomyopathy: Data From the ATTRibute-CM Cardiac Magnetic Resonance Substudy

Presenter: Yousuf Razvi

April 06, 2024

Presentation ACC 2024

Bridge-TIMI 73a: Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk

Presenter: Brian Bergmark

April 07, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.